Abstract
Objective
To assess the efficacy and safety of a single cholecalciferol loading protocol in nursing home (NH) residents taking no VitD supplementation at regular basis.
Design
Randomized single-blind controlled study.
Setting
One NH.
Participants
All residents.
Intervention
From March 21st to May 19th, 2015, NH residents were randomly assigned to either 4x100’000IU to be taken every 2 weeks (treatment group) or an individualized regimen according to baseline 25(OH)VitD level (control group).
Measurements
25(OH) VitD, calcium, phosphorus, parathyroid hormone, alkaline phosphatase, and creatinine serum levels were centrally measured at day 7 after the last dose in both groups, and at baseline in the control group.
Results
111 residents (mean age 85.1±6.7 years) were randomized to the treatment (N=53) or the control group (N=58). No significant difference in terms of demographic characteristics, risk for osteoporosis, and past history of VitD supplementation was measured. At baseline, 37.9%, 25.5% and 5.2% were respectively sub-optimal, insufficient, and deficient for VitD. Whatever the study group, at the 7th day after the last dose of cholecalciferol, 100% of residents reached serum values ≥20ng/mL (p value for non-inferiority <0.001 and p value for superiority p=1.00) and 93.6 vs. 88.2% reached values ≥30ng/mL in the treatment and control group respectively (p value for non-inferiority <0.01 and p value for superiority p=0.48). While mean value was higher in the treatment group (50.2±15.4 vs. 35.8±6.5ng/mL; p <0.0001), none of participants have seen their value >150 ng/mL. Not any biological adverse effects was measured.
Conclusion
This study confirmed that a single loading protocol is at least as effective and safe as tailored regimen in terms of the ability to rapidly normalize 25(OH)VitD values. The often required dosage of 25(OH)VitD is reasonably not necessary to initiate VitD supplementation protocol in this vulnerable population.
Similar content being viewed by others
References
Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin North Am 2012; 38: 141–60.
Carlberg C, Seuter S, Heikkinen S. The first gemone-wide view of vitamin D receptor locations and their mechanistic implications. Anticancer Res 2012; 32: 271–82.
Walsh S, Ludlow AT, Metter EJ et al. Replication study of the vitamin D receptor (VDR) genotype association with skeletal muscle traits and sarcopenia. Aging Clin Exp Res 2015;Sep 28. [Epub ahead of print].
Iolascon G, de Sire A, Calafiore D et al. Hypovitaminosis D is associated with a reduction in upper and lower limb muscle strength and physical performance in postmenopausal women: a retrospective study. Aging Clin Exp Res 2015;Jul 17. [Epub ahead of print].
Beaudart C, Buckinx F, Rabenda V et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2014; 99: 4336–45.
Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:b3692.
Lang PO, Aspinall R. Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients 2015; 7: 2044–60.
Lang PO, Samaras N, Samaras D, Aspinall R. How important is vitamin D in preventing infections? Osteoporos Int 2013; 24: 1537–53.
Ortego-Jurado M, Callejas-Rubio JL, Ríos-Fernández R et al. Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH) D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A «Real-Life» Study. J Osteoporos 2015;729451. doi: 10.1155/2015/729451:729451. doi: 10.1155/2015/.
Tagliabue E, Raimondi S, Gandini S. Meta-analysis of vitamin D-binding protein and cancer risk. Cancer Epidemiol Biomarkers Prev 2015;Sep 12. pii: cebp.0262.2015. [Epub ahead of print].
Kubis AM, Piwowar A. The new insight on the regulatory role of the vitamin D3 in metabolic pathways characteristic for cancerogenesis and neurodegenerative diseases. Ageing Res Rev 2015;Jul 31. pii:S1568-637(15)30010-6.
Sperati F, Vici P, Maugeri-Saccà M et al. Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One 2013;8:e69269.
Nikooyeh B, Neyestani TR. Oxidative stress, type 2 diabetes and vitamin D: past, present and future. Diabetes Metab Res Rev 2015;Sep 26. doi: 10.1002/dmrr.2718. [Epub ahead of print]
Melander O, Modrego J, Zamorano-León JJ et al. New circulating biomarkers for predicting cardiovascular death in healthy population. J Cell Mol Med 2015; 19: 2489–99.
van Groningen L, Opdenoordt S, van Sorge A et al. Cholecalciferol loading dose guideline for vitamin D-dficiency adults. Eur J Endocrinol 2010; 162: 805–11.
Chel V WH, Smit JH, Ooms M, Lips P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 2008; 19: 663–71.
Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med 2016; 176: 175–83.
Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815–22.
Bacon CJ GG, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2010; 20: 1407–15.
Smith H AF, Raphael H, Maslin P et al. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women—a population-based, randomized, doubleblind, placebo-controlled trial. Rheumatology (Oxford) 2007; 46: 1852–7.
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
Lyons RA, Johansen A, Brophy S et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int 2007; 18: 811–8.
Benhamou CL, Souberbielle JC, Cortet B et al. La vitamine D chez l’adulte: recommandation du GRIO. Press Med 2011; 40: 673–82.
Lappe JM, Travers-Gustafson D, Davies KM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586–91.
Singh G, Bonham AJ. A predictive equation to guide vitamin D replacement dose in patients. J Am Board Fam Med 2014; 27: 495–509.
Wijnen H, Salemink D, Roovers L et al. Vitamin D supplementation in ursing home patients: randomized daily dose versus individualized loading dose regimen. Drugs Aging 2015; 32: 371–8.
Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53–8.
Slomski A. Slomski A (2011) IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. JAMA 2011; 305: 453–4, 6.
Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–30.
Dawson-Hughes B, Mithal A, Bonjour JP et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151–4.
Battista C, Viti R, Minisola S et al. Over-supplementation of vitamin D in two patients with primary hyperparathyroidism. Hormones (Athens) 2013; 12: 598–601.
Roth DE, Al Mahmud A, Raqib R et al. Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women. Nutr J 2012;11:114.
Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008; 87: 688–91.
Oliai Araghi S, van Dijk SC, Ham AC et al. BMI and Body Fat Mass Is Inversely Associated with Vitamin D Levels in Older Individuals. J Nutr Health Aging 2015; 19: 980–5.
Spiro A, Buttriss JL. Vitamin D: an overview of Vitamin D status and intake in Europe. Nutr Bull 2014; 39: 322–50.
Lang PO, Samaras D. Aging adults and seasonal influenza: does the vitamin d status (h)arm the body? J Aging Res 2012;2012:806198.
Samefors M, Östgren CJ, Mölstad S et al. Vitamin D deficiency in elderly people in Swedish nursing homes is associated with increased mortality. Eur J Endocrinol 2014; 170: 667–75.
Snijder MB, van Dam RM, Visser M et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90: 4119–23.
Krieg MA, Cornuz J, Jacquet AF et al. Influence of anthropometric parameters and biochemical markers of bone metabolism on quantitative ultrasound of bone in the institutionalized elderly. Osteoporos Int 1998; 8: 115–20.
Engelheart S, Akner G. Dietary intake of energy, nutrients and water in elderly people living at home or in nursing home. J Nutr Health Aging 2015; 19: 265–72.
Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011; 26: 455–7.
Grant WB. The Institute of Medicine did not find the vitamin D-cancer link because it ignored UV-B dose studies. Public Health Nutr 2011; 14: 745–6.
Bischoff-Ferrari HA, Willett WC, Wong JB et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551–61.
Pfeifer M, Begerow B, Minne HW et al. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633–7.
Krause R, Bühring M, Hopfenmüller W et al. Ultraviolet B and blood pressure. Lancet 1998; 352: 709–10.
Zittermann A, Iodice S, Pilz S et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95: 91–100.
Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). Best Pract Res Clin Endocrinol Metab 2011; 25: 681–91.
EFSA (European Food Safety Authority). Scientific Opinion on hte substabtiation of health claims related to vitamin D and maintenance of bone and teeth, absorption and utilisation of calcium and phosporus and maintenance of normal blood calcium concentrations, cell division and thyroid function pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009.
Amrein K, Quraishi SA, Litonjua AA et al. Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab 2014; 99: 1461–9.
Helzlsouer KJ, VDPP Steering Committee. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 4–9.
Tuohimaa P, Tenkanen L, Ahonen M et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108: 104–8.
Mathei C, van Pottelbergh G, Vaes B et al. No relation between vitamin D status and physical performance in the oldest old: results from the Belfrail study. Age Ageing 2013; 342: 186–90.
Janssen HC, Samson MM, Verhaar HJ. Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation. Aging Clin Exp Res 2010; 22: 78–84.
Diamond T, Wong YK, Golombick T. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos Int 2013; 24: 1101–5.
Aloia JF. Clinical Review: The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 2011; 96: 2987–96.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delomas, C., Hertzog, M., Vogel, T. et al. Vitamin D supplementation in nursing home residents: Randomized single cholecalciferol loading protocol vs. individualized loading dose regimen. J Nutr Health Aging 21, 421–428 (2017). https://doi.org/10.1007/s12603-016-0788-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-016-0788-9